Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2013
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103467490A 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
12/25/2013CN102408435B Method for purification of ascomycin from streptomyces fermentation liquid
12/24/2013US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications
12/24/2013US8614207 Inhibitors of hepatitis C virus
12/24/2013CA2714181C Ampk modulators
12/19/2013WO2013186666A1 Tricyclic compounds as kat ii inhibitors
12/19/2013WO2013185211A1 Polymorphic forms of rifaximin
12/19/2013US20130338357 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
12/19/2013US20130338151 Fused ring analogues of anti-fibrotic agents
12/19/2013US20130338142 Imidazopyrazine syk inhibitors
12/19/2013US20130338141 Hiv integrase inhibitors
12/19/2013US20130338139 Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones
12/19/2013US20130338137 Substituted annellated pyrimidines and use thereof
12/19/2013US20130338134 Substituted tricyclic compounds as fgfr inhibitors
12/19/2013CA2876737A1 Polymorphic forms of rifaximin
12/18/2013EP2674430A1 Amino group-containing pyrrolidinone derivative
12/18/2013EP2673279A1 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
12/18/2013EP2673278A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013EP2672970A2 Forms of rifaximin and uses thereof
12/18/2013EP2523961B1 2,5,7-substituted oxazolopyrimidine derivatives
12/18/2013EP2488521B1 Macrocyclic integrase inhibitors
12/18/2013EP2465580B1 Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity
12/18/2013EP2360156B1 Method for manufacturing neuraminic acid derivatives
12/18/2013CN103459400A Novel imidazo-oxazine compound or salt thereof
12/18/2013CN103459399A Tetracyclic indole derivatives for treating hepatitis c virus infection
12/18/2013CN103459391A Compounds for electronic devices
12/18/2013CN103459390A Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
12/18/2013CN103450221A Alpha helix mimetics and methods relating thereto
12/18/2013CN103450220A Novel nitroimidazole compound and application thereof in pharmacy
12/18/2013CN103450218A Indole tricyclic derivative as CRTH2 receptor antagonist
12/17/2013US8609858 Spiro derivatives of parthenin as novel anticancer agents
12/17/2013US8609716 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013CA2613874C Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/12/2013WO2013185103A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013185093A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013185090A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013184878A1 Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
12/12/2013WO2013184876A1 Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
12/12/2013WO2013182503A1 Rapamycin 40-o-cyclic hydrocarbon esters, compositions and methods
12/12/2013WO2013182274A1 Imidazo-oxadiazole and imidazo-thiadiazole derivatives
12/12/2013WO2013181741A1 Imino compounds as protecting agents against ultraviolet radiations
12/12/2013US20130331564 Epothilone derivatives
12/12/2013CA2875718A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2875692A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2875690A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2875628A1 Imidazo-oxadiazole and imidazo-thiadiazole derivatives
12/12/2013CA2875165A1 Imino compounds as protecting agents against ultraviolet radiations
12/11/2013EP2671885A1 Imidazo-oxadiazole and Imidazo-thiadiazole derivatives
12/11/2013EP2671882A1 pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
12/11/2013EP2671881A1 Pesticidally active pyridyl- and pyrimidyl- substituted thiazole derivatives
12/11/2013EP2671583A1 Externally-used drug for treating skin disorder and method for producing same
12/11/2013EP2670756A1 Process for making everolimus
12/11/2013CN103443105A Chroman-spirocyclic piperidine amides as modulators of ion channels
12/11/2013CN102850378B Preparation method of fenspiride
12/10/2013US8604050 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
12/10/2013US8604028 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
12/10/2013CA2625649C Method of tacrolimus extraction and quantification using aqueous detergents
12/05/2013WO2013180194A1 Fused heterocyclic compound
12/05/2013WO2013178322A1 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases
12/05/2013US20130324523 Tau imaging probe
12/05/2013US20130324517 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
12/05/2013US20130323268 Cytotoxic agents comprising new ansamitocin derivatives
12/05/2013CA2875132A1 Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases
12/04/2013EP2669286A1 Spiro tetrahydro-benzothiophen derivatives useful for the treatment of neurodegenerative diseases
12/04/2013EP2668188A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
12/04/2013EP2530071B1 Fused polycyclic compound and organic light-emitting device using the compound
12/04/2013CN103421023A Synthesis process for temsirolimus
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN102584736B Method for catalyzing and oxidizing hydroxamic acids
12/03/2013US8598368 Stable neutral nitric oxide source
12/03/2013US8598358 Synthetic intermediate of oxazole compound and method for producing the same
12/03/2013US8598340 Spirooxazine radical derivatives and reversible isomerization reaction
12/03/2013US8598164 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
12/03/2013US8598154 Pyridyl-amine fused azadecalin modulators
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/2013
11/28/2013WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/28/2013US20130317225 New forms of rifaximin and uses therof
11/28/2013US20130317015 Oxadiazoanthracene compounds for the treatment of diabetes
11/28/2013US20130317014 Inhibitors of beta-secretase
11/28/2013US20130317004 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/28/2013US20130316999 Substituted oxazolidinones and their use in the field of blood coagulation
11/27/2013EP2665716A1 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
11/27/2013CN103415525A Bromodomain inhibitors and uses thereof
11/27/2013CN103408571A Crystal form I of rifabutin, and preparation method and application thereof
11/27/2013CN101896183B Bicyclic amides for enhancing glutamatergic synaptic responses
11/26/2013CA2532982C Thienopyridine and furopyridine kinase inhibitors
11/26/2013CA2335240C Cyanine dyes and synthesis methods thereof
11/21/2013WO2013172171A1 Cyclic carbodiimide compound, polyester film, back sheet for solar cell module and solar cell module
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013US20130310410 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
11/21/2013US20130310409 Forms of rifaximin and uses thereof
11/20/2013EP2419432B1 Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
11/20/2013EP2285808B1 Spiro-indole derivatives for the treatment of parasitic diseases
11/20/2013EP1781663B1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/20/2013EP1709044B2 Oxazolidinone-quinolone hybrid antibiotics
11/20/2013CN103403010A Inhibitors of polo-like kinase
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 220